Helping cancer patients take their medicine
by Microfluidics Corp.
In this case study, a cancer treatment drug being tested in a trial at Johns Hopkins Oncology Center is delivered intravenously — with far fewer side effects for patients — with help from Microfluidics Corp.'s Microfluidizer processor.
| Published: | 1998 |
| Format: | |
| Length: | 2 pages |
| Type: | Case Study |
| Language: | English |
.
SPONSORED REPORTS
